Skip to main content

Advertisement

Table 2 Patient demographics and clinicpathological characteristics

From: Immunohistochemical analysis of cancer stem cell markers in pancreatic adenocarcinoma patients after neoadjuvant chemoradiotherapy

  NACRT (n = 17) Non-NACRT (n = 11) P-value
Age(mean ± SD) 59.9 ± 7.9 63.6 ± 10.4 0.287*1
Gender(male/female) 8/9 6/5 1.000*2
Operative procedures PD/DP/TP 13/3/1 10/1/0 1.000*2
Portal vein resection 70.6% (12/17) 63.6% (7/11) 1.000*2
cT(1/2/3/4) 0/0/17/0 0/0/11/0 1.000*2
cN(0/1) 11/6 6/5 0.701*2
pT(0/1/2/3/4) 0/1/16/0 0/0/11/0 1.000*2
pN(0/1) 13/4 5/6 0.125*2
Histological classification G1-2/G3/ungradeable 11/5/1 8/3/0 1.000*2
Residual tumor R0/R1-2 17/0 9/2 0.146*2
Tumor destruction (Evan’s criteria)I/IIa/IIb/III/IV 1/7/7/2/0   
  1. SD: standard deviation; PD: pancreatoducdenectomy; DP: distal pancreatectomy; TP total pancreatectomy. *1: Unpaired t-test. *2: Fisher’s exact test.